Literature DB >> 22948992

Superior vena cava syndrome as a presentation of metastatic prostate cancer.

Hyun Don Yun1, William B Ershler.   

Abstract

Superior vena cava (SVC) syndrome is an uncommon complication of malignant disease caused by the obstruction of venous blood flow in the SVC. When present, a diagnosis of lung cancer or lymphoma will be made in approximately 95% of cases. Although other malignant diseases are occasionally associated with SVC, its occurrence in patients with prostate cancer is rare. We present a case of a patient presenting with SVC obstruction who was subsequently diagnosed with prostate adenocarcinoma. The patient has been successfully treated with GnRH agonist. This case reflects the importance of a full clinical assessment and pathological confirmation of suspected tumour prior to treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948992      PMCID: PMC4543844          DOI: 10.1136/bcr-2012-006480

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Superior vena cava obstruction in prostate cancer.

Authors:  S E Old
Journal:  Clin Oncol (R Coll Radiol)       Date:  1999       Impact factor: 4.126

2.  Generalized lymphadenopathy: a rare presentation of disseminated prostate cancer.

Authors:  Basak Oyan; Huseyin Engin; Suayib Yalcin
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

Review 3.  Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: report of a case, review of the literature, and analysis of chemokine receptor expression.

Authors:  Gustavo A Heresi; Jingcheng Wang; Russell Taichman; Julio A Chirinos; Jacinto J Regalado; Daniel M Lichtstein; Joseph D Rosenblatt
Journal:  Urol Oncol       Date:  2005 Jul-Aug       Impact factor: 3.498

Review 4.  Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Authors:  Leland W K Chung; Adam Baseman; Vasily Assikis; Haiyen E Zhau
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

5.  Prostate adenocarcinoma manifesting as generalized lymphadenopathy.

Authors:  Fabiana M Moura; Luisimara T Garcia; Lúcia P F Castro; Teresa C A Ferrari
Journal:  Urol Oncol       Date:  2006 May-Jun       Impact factor: 3.498

6.  Superior vena cava obstruction due to prostate carcinoma.

Authors:  R C McGarry
Journal:  Urology       Date:  2000-03       Impact factor: 2.649

Review 7.  Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.

Authors:  Eric C Kauffman; Victoria L Robinson; Walter M Stadler; Mitchell H Sokoloff; Carrie W Rinker-Schaeffer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

8.  Metastatic carcinoma of the prostate presenting as a superior vena cava syndrome.

Authors:  C Montalbán; M A Moreno; J P Molina; I Hernanz; C Bellas
Journal:  Chest       Date:  1993-10       Impact factor: 9.410

9.  Prostatic cancer with an unusual presentation: polymyositis and mediastinal adenopathy.

Authors:  Y Park; M W Oster; M R Olarte
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  1 in total

1.  Internal jugular venous thrombosis due to Trousseau's syndrome as the presenting feature of metastatic prostate carcinoma: a case report.

Authors:  Asela Rasika Bandara; Harith Wimalarathna; Ranjith Kalupahana; Sonali Sihindi Chapa Gunathilake
Journal:  J Med Case Rep       Date:  2016-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.